002262 恩华药业
2025/09 - 九个月
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资102,2945.11%97,31872,54678,38492,343
投资性房地产50,362-3.22%52,03650,51652,62954,244
固定资产1,220,204-1.42%1,237,8231,141,1561,145,3131,065,820
在建工程298,237-3.60%309,381293,76092,07117,213
无形资产227,483-1.99%232,090190,466111,10495,982
商誉0--0000
其他非流动资产531,92917.73%451,806325,191351,249328,402
2,430,5092.10%2,380,4542,073,6341,830,7501,654,003

流动资产
货币资金1,783,39825.91%1,416,3892,158,9461,532,2141,607,591
应收账款1,523,0712.20%1,490,2281,034,736820,839676,639
存货880,80633.17%661,394628,637716,340604,335
其他流动资产2,461,907-1.19%2,491,5411,432,2411,581,0101,154,619
6,649,1819.73%6,059,5525,254,5614,650,4034,043,183

流动负债
短期借款0-100.00%15,00055,00030,00038,000
应付票据238,924-14.83%280,52560,91529,55823,883
应付帐款255,624-11.19%287,828216,284226,181243,290
其他流动负债417,636-13.51%482,888481,829508,204376,783
912,185-14.45%1,066,241814,028793,943681,957
流动资产净值5,736,99614.89%4,993,3114,440,5343,856,4603,361,226
资产总额减流动负债8,167,50510.76%7,373,7656,514,1685,687,2105,015,229

非流动负债
长期借款2300.00%230230230230
应付债券0--0000
其他非流动负债91,718-8.30%100,019103,830103,253111,266
91,948-8.28%100,249104,060103,483111,496

总权益
    实收股本1,015,787-0.04%1,016,1771,007,5881,007,5881,007,588
    储备项目7,088,09812.79%6,284,1455,426,5534,613,9263,913,100
股东权益8,103,88411.01%7,300,3226,434,1415,621,5154,920,688
非控股权益(28,328)5.68%(26,806)(24,034)(37,788)(16,955)